How Should My Group Deal With an Unvaccinated Student?
The magazine’s Ethicist columnist on the obligations faced by those who choose not to be vaccinated against Covid-19. View original article Contributor: Kwame Anthony Appiah
The magazine’s Ethicist columnist on the obligations faced by those who choose not to be vaccinated against Covid-19. View original article Contributor: Kwame Anthony Appiah
For now, the best way to show that you’ve been inoculated against the coronavirus is a simple white card. Here, your key questions answered. View original article Contributor: Concepción de León
An analysis of health insurance records of almost 2 million coronavirus patients found new issues in nearly a quarter — including those whose Covid infection was mild or asymptomatic. View original article Contributor: Pam Belluck
Creating a digital certificate of vaccination against the coronavirus is one of the hottest debates right now. What’s keeping it from happening, and why are some people opposed? View original article Contributor: Ceylan Yeginsu
In updated recommendations, the federal health agency said both domestic and international travel was low risk for fully vaccinated Americans. But travel remains far from simple. View original article Contributor: Ceylan Yeginsu
The state has done so well with vaccination that it can now safely drop its pandemic restrictions, Gov. Phil Scott said on Monday. View original article Contributor: Daniel E. Slotnik
Jittery pet owners are asking vets, animal poison control centers and Twitter. Read on for answers. View original article Contributor: Jan Hoffman
In early 2020, Kristian Andersen wrote to Anthony Fauci about the possibility of an engineered coronavirus. His research has since dispelled those suspicions. View original article Contributor: James Gorman and Carl Zimmer
Shi Zhengli, a top virologist, says in a rare interview that speculation about her lab in Wuhan is baseless. But China’s habitual secrecy makes her claims hard to validate. View original article Contributor: Amy Qin and Chris Buckley
The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots. View original article Contributor: Carl Zimmer